Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says

Medicare has severely restricted access to the medication Leqembi, which costs $26,500 per year, because the FDA approved it just on an expedited basis.

from Health and Science https://ift.tt/6KrX4MW
https://ift.tt/fuFmXTC
https://ift.tt/c3Q2JXS